Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesisG Hartmann, L Naldini, K M Weidner, et al.
Clinical Chemistry and Laboratory Medicine|July 25, 2000
Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infectionE M Kittl, J Hofmann, G Hartmann, et al.
The Journal of Infectious Diseases|March 14, 1998
In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccinationU T Hacker, T Jelinek, S Erhardt, et al.
The Journal of Clinical Investigation|December 1, 1995
Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?E Fiebiger, D Maurer, H Holub, et al.
Clinical & Experimental Metastasis|May 6, 1998
C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cellsS Lin, D Rusciano, P Lorenzoni, et al.
Biochemical and Biophysical Research Communications|January 7, 2004
Structural studies of oligonucleotides containing G-quadruplex motifs using AFML T Costa, M Kerkmann, G Hartmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytesG Hartmann, A Krug, M Bidlingmaier, et al.
EXS|January 1, 1993
Molecular characteristics of HGF-SF and its role in cell motility and invasionK M Weidner, G Hartmann, L Naldini, et al.
Cytokine|March 8, 2000
High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive proteinG Hartmann, M Tschöp, R Fischer, et al.
Investigative Radiology|October 8, 2009
Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibilityJosef Vymazal, Elmar Spuentrup, Gerardo Cardenas-Molina, et al.
Pageof 19